This past week there was a shake-up in the medical devices community when Minnesota-based medical technologies company Medtronic acquired CoreValve Inc. and Ventor Technologies. The acquisitions totaled $1 billion and will make Medtronic's presence in the replacement heart valves much stronger.
Ventor Technologies, which Medtronic acquired for $325 million, develops transcatheter heart valve technologies for the treatment of aortic valve disease. Ventor was founded in 2004 and is privately-held out of Israel.
"The combination of Ventor Technologies and our strengths in research and development, operations, medical education and market development will improve patient outcomes and expand physician adoption among both surgeons and interventional cardiologists," Bill Hawkins, chairman and CEO of Medtronic said in a prepared statement.
CoreValve Inc., which Medtronic acquired for $700 million, develops transcatheter, transfemoral aortic valve replacement product. CoreValve was founded in 2001 and is based out of Irvine, CA.
"The acquisition of CoreValve gives additional momentum to our strategies for growth and will improve the quality of care for more than 300,000 people worldwide with severe aortic stenosis," said Hawkins in another statement. "Our manufacturing and global distribution strengths will accelerate the use of this life-saving technology."
(Information sourced from Medtronic Press Releases)
Click here to read more about Medtronic's acquisition of CoreValve Inc.
Click here to read more about Medtronic's acquisition of Ventor Technologies Ltd.
Ventor Technologies, which Medtronic acquired for $325 million, develops transcatheter heart valve technologies for the treatment of aortic valve disease. Ventor was founded in 2004 and is privately-held out of Israel.
"The combination of Ventor Technologies and our strengths in research and development, operations, medical education and market development will improve patient outcomes and expand physician adoption among both surgeons and interventional cardiologists," Bill Hawkins, chairman and CEO of Medtronic said in a prepared statement.
CoreValve Inc., which Medtronic acquired for $700 million, develops transcatheter, transfemoral aortic valve replacement product. CoreValve was founded in 2001 and is based out of Irvine, CA.
"The acquisition of CoreValve gives additional momentum to our strategies for growth and will improve the quality of care for more than 300,000 people worldwide with severe aortic stenosis," said Hawkins in another statement. "Our manufacturing and global distribution strengths will accelerate the use of this life-saving technology."
(Information sourced from Medtronic Press Releases)
Click here to read more about Medtronic's acquisition of CoreValve Inc.
Click here to read more about Medtronic's acquisition of Ventor Technologies Ltd.
